The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Share News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

WINNERS & LOSERS SUMMARY: M&A Speculation And Upgrade Boost Morrisons

Thu, 03rd Sep 2015 09:42

LONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Thursday.
----------
FTSE 100 - WINNERS
----------
easyJet, up 6.3%. The low-cost airline upgraded its full-year profit guidance following a strong summer trading season. The FTSE 100 airline said its pretax profit for the financial year to the end of September is now expected to be GBP675 million to GBP700 million, up from its previous guidance of GBP620 million to GBP660 million. The group said its strong revenue performance over the summer has more than offset any cost challenges it has faced this year and said it passenger numbers and load factor both hit record levels in August.

Wm Morrison Supermarkets, up 4.8%. The supermarket was in demand after a report in The Daily Telegraph suggested South African billionaire Christo Wiese is now training his sights on the UK supermarket industry. Wiese, who owns a 19% stake in frozen food retailer Iceland and who has been linked with a takeover of Wm Morrison Supermarkets PLC in the past, told the Telegraph that his investment firm, Brait, may make its next venture in the UK supermarket sector. The stock was also upgraded Thursday to Neutral from Sell by UBS, with a price target of 175p, up from 165p. It was quoted at 169.90p Thursday morning.
----------
FTSE 250 - WINNERS
----------
Lookers, up 6.7%. The motor retailer and aftersales services provider said it has struck an GBP87.5 million cash deal to acquire Addison Motors, which trades as Benfield Motor Group. Benfield is based in Newcastle-upon-Tyne and operates 30 car dealerships across the UK, offering sales, service, parts and bodyshop facilities for new and used cars and commercial vehicles, Lookers said. Analysts hailed the deal, with Numis describing the acquisition as a "major step" for Lookers. The broker said that "the new company helps to consolidate Lookers' position with key original equipment manufacturers and dovetails nicely in terms of location," adding it expects the acquisition to raise Lookers' level of profitability "significantly".

Virgin Money Holdings, up 3.0%. Investec upgraded the financial services provider to Buy from Hold, saying the economic fundamentals which will drive its share price performance are all positive at present.
----------
FTSE 250 - LOSERS
----------
Go-Ahead Group, down 6.7%. The transport operator said its annual pretax profit was pulled lower by exceptional costs, but said its underlying performance was strong and its revenue surged higher thanks to stronger-than-expected trading in its rail unit. Still, it expects to hit its GBP100 million operating profit target for the bus operations in the 2016-17 financial year, a year later than it had anticipated. Its pretax profit for the year to June 27 was GBP78.7 million, down from GBP91.2 million a year earlier, as the group booked GBP8.8 million in exceptional costs, having booked a GBP12.1 million gain a year earlier. Stripping out exceptional costs, Go-Ahead's pretax profit was up to GBP96.6 million from GBP84.9 million.
----------
MAIN MARKET AND AIM - WINNERS
----------
African Potash, up 13%. The company said it has signed its third and largest offtake agreement to supply fertiliser through its previously signed agreement to build a production and distribution platform for fertiliser in Africa. The company has signed a memorandum of understanding with an unnamed Zimbabwean fertiliser supply company to provide 150,000 metric tonnes of fertiliser per year.

Dart Group, up 10%. The leisure travel, distribution and logistics company said it is confident its full-year results will materially outpace market expectations following robust summer trading in its leisure travel arm and a solid performance in its Fowler Welch unit. Dart said the early indications for the winter season in the leisure travel arm are satisfactory, but it said it has seen continued strong demand over the summer months for its package holiday and flight-only products. Dart also said it has entered into a deal with aerospace giant Boeing to buy 27 new Boeing 737-800NG aircraft, to be delivered between September 2016 and April 2018.

Motif Bio, up 8.6%. The biopharmaceutical company said the US Food and Drug Administration has granted fast-track designation to its Iclaprim drug. The intravenous drug is used to treat acute bacterial skin and skin structure infections and hospital-acquired bacterial pneumonia. Amphion Innovations, up 8.8%, also benefited from the rise in value of Motif Bio shares in the first half and its shares were higher on the back of the Motif Bio news.
----------
MAIN MARKET AND AIM - LOSERS
----------
Forbidden Technologies, down 12%. The company which owns and develops cloud video platform Forscene and video social network eva, said it made a GBP1.4 million pretax loss in the six months to June 30, compared with GBP1.2 million in the corresponding half the prior year. Revenue was down to GBP327,338 from GBP348,077, while operating costs rose to GBP1.4 million from GBP1.3 million. Deferred and future revenue from agreed deals increased to GBP220,000 from GBP33,000 six months earlier.
----------
By Sam Unsted; samunsted@alliancenews.com; @SamUAtAlliance

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
3 Jul 2018 10:47

Motif Bio Director Robert Bertoldi To Resign From Role July 16

LONDON (Alliance News) - Clinical-stage biopharmaceutical company Motif Bio PLC said Tuesday that Director Robert Bertoldi will resign from the board with effect on July 16.Chief Executive

Read more
23 May 2018 14:39

Amphion Sells 8.9 Million Shares In Motif Bio To Repay Loan Facility (ALLISS)

LONDON (Alliance News) - Amphion Innovations PLC said on Wednesday it sold 8.9 million shares in partner company Motif Bio PLC to partially repay a loan facility, as well as to fund ongoing &

Read more
17 May 2018 14:56

UPDATE: Motif Bio Completes GBP10 Million Fundraise Through Placing (ALLISS)

LONDON (Alliance News) - Biopharmaceutical firm Motif Bio PLC said it has successfully raised GBP10 million via an accelerated bookbuild exercise on Thursday.The company placed 32.3 million

Read more
17 May 2018 12:20

Motif Bio To Raise GBP10 Million Via Accelerated Share Bookbuild (ALLISS)

LONDON (Alliance News) - Motif Bio PLC said it plans to raise GBP10 million via an accelerated bookbuild exercise, which will launch on Thursday.The funds raised will be used by the company

Read more
19 Apr 2018 13:59

Motif Bio's Iclaprim Delivers Continued Good Test Results

LONDON (Alliance News) - Motif Bio PLC on Thursday said iclaprim delivered further positive results as part of its REVIVE-2 phase three trial.Motif Bio previously had said iclaprim showed a

Read more
20 Mar 2018 11:08

Motif Bio Delays Iclaprim New Drug Application, Shares Fall

LONDON (Alliance News) - Motif Bio PLC's shares fell on Tuesday as the biopharmaceutical company said it has pushed back the date for its new drug application submission a

Read more
7 Mar 2018 13:24

Motif Bio Issues 178,571 Shares Following Warrants Exercise (ALLISS)

LONDON (Alliance News) - Motif Bio PLC said Wednesday it has raised GBP57,499 through the issue of 178,571 shares at a price of 32.2 pence per of

Read more
31 Oct 2016 10:58

Motif Bio may need to raise cash as antibiotic trial accelerates

(ShareCast News) - As it prepares to list on the Nasdaq, AIM-listed antibiotics developer Motif Bio said it was likely to need extra funding as enrolments for its latest clinical trial were going faster than expected. Patient enrolment in Motif's Revive 1 phase-three trial has exceeded projections a

Read more
9 Aug 2016 09:43

WINNERS & LOSERS SUMMARY: Worldpay Bid Up After Strong First Half

Read more
13 Jul 2016 09:43

WINNERS & LOSERS SUMMARY: Poundland Jumps On Steinhoff Takeover Deal

Read more
13 Jul 2016 08:13

Motif Bio Shares Rise As It Files To List On NASDAQ Market (ALLIPO)

Read more
23 Jun 2016 09:01

Amphion Reports Huge Net Asset Value Rise Thanks To Motif Bio

Read more
28 Apr 2016 09:01

Amphion Innovations To Draw Debt To Repay Existing Borrowings

Read more
20 Apr 2016 07:31

Motif Bio Loss Widens In 2015 As It Continues Iclaprim Progression

Read more
14 Apr 2016 07:52

Motif Bio Appoints New Chief Financial Officer, Clinical Operations VP

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.